Prism Medico and Pharmacy: Board Meeting Intimation for Consideration Approval And Taking On Record The Unaudited Standalone Financial Results Of The Company Along With The Limited Review Report For The Quarter Ended 31St December 2025.

Prism Medico And Pharmacy Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/02/2026 inter alia to consider and approve the Unaudited Standalone Financial Results of the company along with the Limited Review Report for the quarter ended 31st December 2025 as per Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015.